In their review paper recently published in the Indian Journal of Clinical Biochemistry, a group of authors discusses currently available and forthcoming CRISPR-based diagnostic assays, as well as the ...

In a study posted to the medRxiv* pre-print server, a team of researchers evaluated the performance of two different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostic assays, ...

BD (Becton, Dickinson and Company) recently expanded its European infectious disease diagnostics portfolio after IVDR ...

Historically, pharmaceutical and diagnostic companies in the U.S. have inhabited parallel regulatory universes. Although both sets of firms are overseen by the FDA and are subject to some identical ...

An expert describes the technical hurdles behind designing the next generation of in vitro diagnostics systems. Sagentia is at the forefront of research and development in clinical diagnostics, having ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of ...

HIV-1 viral load monitoring is central to the effective management and treatment of HIV infection. Accurate quantification of viral RNA in plasma not only guides antiretroviral therapy but also offers ...

The study has shown that a cancer diagnostic assay designed with Asian-centric biomarkers is safe and precise and can can measure 4 major classes of biomarkers, allowing for molecular characterisation ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation (IVDR) certification for PD-L1 ...

The COVID-19 pandemic and geopolitical conflict in Eastern Europe have done irreparable damage to the underpinnings of the clinical diagnostic industry. These events significantly impacted the supply ...